14158 Results (Page 559 of 567)
All Market Research Reports
UAE Congestive Heart Failure Therapeutics Market Analysis
The UAE Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $52 Mn in 2022 to $87 Mn by 2030, with a CAGR of 6.8% during the forecast period of 2022-2030. The market is growing due to the presence of increasing government initiatives that actively encourage research and collaboration, the rising prevalence of cardiovascular disease, and a favorable environment conducive to advancements in therapeutics. The UAE Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, AstraZeneca, Julphar, RAK Pharma, Pharmed, Cipla, etc, among various others.
Spain Exosome Research Market Analysis
The Spain Exosome Research Market was valued at $3.3 Mn in 2023 and is projected to grow at a CAGR of 15% from 2023 to 2023, to $8.7 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Laminar Pharmaceuticals, Thermo Fisher Scientific, Medina, NX Pharmagen, Malvern Instruments among others.
South Africa Digital Biomarkers Market Analysis
South Africa Digital Biomarkers Market was valued at $18.85 Mn in 2023 and is predicted to grow at a CAGR of 23.53% from 2023 to 2030, to $82.74 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, rising healthcare costs, and an aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Japan Medication Access Programs Market Analysis
The Japan Medication Access Programs Market was valued at $341.2 Mn in 2023 and is predicted to grow at a CAGR of 15.1% from 2023 to 2030, to $913.2 Mn by 2030. The key drivers of this industry include an aging population, government support, and a high prevalence of diseases. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
UAE Cardiac Resynchronization Therapy Market
UAE Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $38 Mn by 2030 with a 6% CAGR. The increasing worldwide incidence of heart failure, propelled by aging demographics and cardiovascular diseases linked to lifestyle, emerges as a significant factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, prominent players in this market encompass Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.
UK Congestive Heart Failure Therapeutics Market Analysis
The UK Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $268 Mn in 2022 to $361 Mn by 2030, with a CAGR of 3.8% during the forecast period of 2022-2030. The key drivers include the escalating prevalence of risk factors, continuous innovations in CHF therapies, and an increased government healthcare expenditure, fostering improved access, all collectively propelling market growth. The UK Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Novartis, Boehringer Ingelheim, Amgen, Bristol-Myers Squibb, Johnson and Johnson, Eli Lilly, Hikma Pharmaceuticals, Wockhardt, Medivet Pharmaceuticals, etc., among various others.
India Digital Biomarkers Market Analysis
India Digital Biomarkers Market was valued at $52.74 Mn in 2023 and is predicted to grow at a CAGR of 25.3% from 2023 to 2030, to $255.74 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing smartphone penetration, government initiatives, and a growing focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Malaysia Medication Access Programs Market Analysis
The Malaysia Medication Access Programs Market was valued at $8.8 Mn in 2023 and is predicted to grow at a CAGR of 14.8% from 2023 to 2030, to $23.2 Mn by 2030. The key drivers of this industry include disease burden, pharmaceutical industry growth, and government initiatives. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Philippines Cardiac Resynchronization Therapy Market
Philippines Cardiac Resynchronization Therapy Market valued at $11 Mn in 2022, projected to reach $16 Mn by 2030 with a 5.5% CAGR. The notable increase in heart failure cases worldwide, propelled by aging demographics and lifestyle-associated cardiovascular ailments, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
US Congestive Heart Failure Therapeutics Market Analysis
The US Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $4.326 Bn in 2022 to $5.830 Bn by 2030, with a CAGR of 3.8% during the forecast period of 2022-2030. The key drivers of the market in the US include the increasing prevalence of risk factors, alongside rising investments in healthcare and growing initiatives for patient education and awareness, collectively fueling market expansion. The US Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, etc., among various others.
UK Exosome Research Market Analysis
The UK Exosome Research Market was valued at $4.4 Mn in 2023 and is projected to grow at a CAGR of 14% from 2023 to 2023, to $11 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as AMS Biotechnology, Evox Therapeutics, Thermo Fisher Scientific among others.
Canada Physiotherapy Equipment Market Analysis
The Canada Physiotherapy Equipment Market was valued at $1,672 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $2,720.19 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Medelco, Ortho Canada, Enraf-Nonius BV, and Body Best among others.
Singapore Cardiac Resynchronization Therapy Market
Singapore Cardiac Resynchronization Therapy Market valued at $6 Mn in 2022, projected to reach $9 Mn by 2030 with a 5.6% CAGR. The notable increase in heart failure cases worldwide, propelled by aging demographics and lifestyle-associated cardiovascular ailments, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
US Exosome Research Market Analysis
The US Exosome Research Market was valued at $71 Mn in 2023 and is projected to grow at a CAGR of 14% from 2023 to 2023, to $177.6 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, NanoSomix, NX Pharmagen, Malvern Instruments, Capricor Therapeutics among others.
US Physiotherapy Equipment Market Analysis
The US Physiotherapy Equipment Market was valued at $8,778 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $12,517.16 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are EMS Physio, Zynex Medical Inc., Invacare Corporation, and Baxter International among others.
Philippines Medication Access Programs Market Analysis
The Philippines Medication Access Programs Market was valued at $12.1 Mn in 2023 and is predicted to grow at a CAGR of 15.1% from 2023 to 2030, to $32.3 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and increasing healthcare awareness. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Saudi Arabia Cardiac Resynchronization Therapy Market
Saudi Arabia Cardiac Resynchronization Therapy Market valued at $82 Mn in 2022, projected to reach $135 Mn by 2030 with a 6.5% CAGR. The increasing worldwide incidence of heart failure, propelled by aging demographics and cardiovascular diseases linked to lifestyle, emerges as a significant factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, prominent players in this market encompass Medtronic, Abbott, Boston Scientific, Johnson & Johnson, Biotronik, St. Jude Medical, LivaNova, MicroPort, Sorin Group, and Siemens Healthineers.
Saudi Arabia Physiotherapy Equipment Market Analysis
The Saudi Arabia Physiotherapy Equipment Market was valued at $355.30 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $637.09 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, Fitness Equipment, Medexsol, and Medical Elements Co. among others.
Vietnam Medication Access Programs Market Analysis
The Vietnam Medication Access Programs Market was valued at $27.4 Mn in 2023 and is predicted to grow at a CAGR of 14.83% from 2023 to 2030, to $72.3 Mn by 2030. The key drivers of this industry include public-private partnerships, government support, and increasing disease burden. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Mexico Cardiac Resynchronization Therapy Market
Mexico Cardiac Resynchronization Therapy Market valued at $72 Mn in 2022, projected to reach $108 Mn by 2030 with a 5.25% CAGR. The global rise in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a key factor contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, leading participants in this market include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.
Brazil Dental Consumables Market Analysis
The Brazil Dental Consumables Market was valued at $845 Mn in 2023 and is projected to grow at a CAGR of 9.0% from 2023 to 2023, to $1544.7 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Institut Straumann AG, Coltene, EDLO ITM, ZimVie Inc, SIN Implant System among others.
UAE Physiotherapy Equipment Market Analysis
The UAE Physiotherapy Equipment Market was valued at $104.50 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $181.43 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, Medicaregt, EMS Physio Ltd., and Bionex Medical Equipment among others.
Egypt Medication Access Programs Market Analysis
The Egypt Medication Access Programs Market was valued at $15.4 Mn in 2023 and is predicted to grow at a CAGR of 16.1% from 2023 to 2030, to $43.7 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and patient education and awareness. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Malaysia Cardiac Resynchronization Therapy Market
Malaysia Cardiac Resynchronization Therapy Market valued at $8 Mn in 2022, projected to reach $12 Mn by 2030 with a 5.2% CAGR. The notable increase in heart failure cases worldwide, propelled by aging demographics and lifestyle-associated cardiovascular ailments, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Biotronik, Boston Scientific, Medtronic, Nihon Kohden, Oscor, Siemens Healthineers, Sorin Group, MicroPort CRM, and Osram Health.
Canada Dental Consumables Market Analysis
The Canada Dental Consumables Market was valued at $2704 Mn in 2023 and is projected to grow at a CAGR of 8.0% from 2023 to 2023, to $4634.2 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, 3M, Straumann Holding, Henry Schein, Patterson Companies among others.
